Cargando…

Comparison of Left Atrial Appendage Occlusion versus Non-Vitamin-K Antagonist Oral Anticoagulation in High-Risk Atrial Fibrillation: An Update

Transcatheter left atrial appendage occlusion (LAAO) is non-inferior to vitamin K antagonists (VKAs) in preventing thromboembolic events in atrial fibrillation (AF). Non-vitamin K antagonists (NOACs) have an improved safety profile over VKAs; however, evidence regarding their effect on cardiovascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Shaojie, Chun, K. R. Julian, Ling, Zhiyu, Liu, Shaowen, Zhu, Lin, Wang, Jiazhi, Schratter, Alexandra, Acou, Willem-Jan, Kiuchi, Márcio Galindo, Yin, Yuehui, Schmidt, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230807/ https://www.ncbi.nlm.nih.gov/pubmed/34208117 http://dx.doi.org/10.3390/jcdd8060069

Ejemplares similares

Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control
por: Chen, Shaojie, et al.
Publicado: (2022)

Association of Preoperative Renin-Angiotensin System Inhibitors With Prevention of Postoperative Atrial Fibrillation and Adverse Events: A Systematic Review and Meta-analysis
por: Chen, Shaojie, et al.
Publicado: (2019)

Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
por: Ding, Wern Yew, et al.
Publicado: (2022)

Percutaneous Left Atrial Appendage Occlusion in Comparison to Non‐Vitamin K Antagonist Oral Anticoagulant Among Patients With Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2022)

Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation
por: Labori, Frida, et al.
Publicado: (2021)

Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update
por: De Backer, O, et al.
Publicado: (2014)

Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Cancer
por: Shabtaie, Samuel A., et al.
Publicado: (2023)

Left Atrial Appendage Occlusion for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Collado, Fareed Moses S., et al.
Publicado: (2021)

Comparison Between Oral Anticoagulation and Left Atrial Appendage Occlusion in the Prevention of Stroke With Regard to Non-Valvular Atrial Fibrillation
por: Sandhu, Osama, et al.
Publicado: (2020)

Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation—One-Year Survival
por: Tiosano, Shmuel, et al.
Publicado: (2023)

Left atrial appendage occlusion: A better alternative to anticoagulation?
por: Akin, Ibrahim, et al.
Publicado: (2017)

Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
por: Contractor, Tahmeed, et al.
Publicado: (2011)

Pulmonary Vein Occlusion After Surgical Atrial Fibrillation Ablation and Left Atrial Appendage Occlusion
por: Patel, Neel, et al.
Publicado: (2022)

Is Left Atrial Appendage Occlusion Really Efficacious in Avoiding Administrating Anticoagulant Drugs for the Prevention of Cardioembolic Events in Patients With Atrial Fibrillation?
por: De Vecchis, Renato, et al.
Publicado: (2019)

Impact of Oral Anticoagulation Therapy Versus Left Atrial Appendage Occlusion on Cognitive Function and Quality of Life in Patients With Atrial Fibrillation
por: Mohanty, Sanghamitra, et al.
Publicado: (2021)

The effects of different physical activities on atrial fibrillation in patients with hypertension and chronic kidney disease
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2017)

Biomarkers for Predicting Left Atrial or Left Atrial Appendage Thrombus in Anticoagulated Patients with Nonvalvular Atrial Fibrillation
por: Zhou, Xue, et al.
Publicado: (2020)

Oral Anticoagulation Use and Left Atrial Appendage Occlusion in LAAOS III
por: Connolly, Stuart J., et al.
Publicado: (2023)

Left atrial appendage occlusion should be offered only to select atrial fibrillation patients
por: Munir, Muhammad Bilal, et al.
Publicado: (2022)

Safety and efficacy of ablation for atrial fibrillation in combination with left atrial appendage occlusion in octogenarians
por: Zhang, Peng‐Pai, et al.
Publicado: (2023)

Percutaneous interventions in elderly patients with atrial fibrillation: left atrial ablation and left atrial appendage occlusion
por: Mikhaylov, Evgeny N, et al.
Publicado: (2017)

Left Atrial Appendage Occlusion
por: Mirdamadi, Ahmad, et al.
Publicado: (2013)

Left Atrial Appendage Thrombus in Patients with Nonvalvular Atrial Fibrillation before Catheter Ablation and Cardioversion: Risk Factors beyond the CHA2DS2-VASc Score
por: Cai, Yangwei, et al.
Publicado: (2022)

Short-Term Apixaban for Documented Left Atrial Appendage Thrombus in High-Risk Atrial Fibrillation Patients Undergoing Left Atrial Appendage Occlusion
por: Ding, Wern Yew, et al.
Publicado: (2020)

Long-Term Efficacy and Anticoagulation Strategy of Left Atrial Appendage Occlusion During Total Thoracoscopic Ablation of Atrial Fibrillation to Prevent Ischemic Stroke
por: Kim, Ju Youn, et al.
Publicado: (2022)

Low Dose of Direct Oral Anticoagulants after Left Atrial Appendage Occlusion
por: Cepas-Guillen, Pedro Luis, et al.
Publicado: (2021)

Is Left Atrial Appendage Occlusion Always Better than Direct Oral Anticoagulants?
por: Kim, Jun
Publicado: (2021)

Left atrial appendage exclusion in atrial fibrillation
por: Rozen, Guy, et al.
Publicado: (2022)

Right atrial appendage firing in atrial fibrillation
por: Baptiste, Florian, et al.
Publicado: (2022)

Atrial fibrillation and chronic kidney disease: A bad combination
por: Kiuchi, Márcio Galindo
Publicado: (2018)

Early Experience Using a Left Atrial Appendage Occlusion Device in Patients with Atrial Fibrillation
por: Kim, Yung Ly, et al.
Publicado: (2012)

Rudimentary left atrial appendage in atrial fibrillation, congenital occlusion device, or continued thrombotic risk
por: Dawdy, John, et al.
Publicado: (2021)

Concomitant Atrial Fibrillation Ablation and Appendage Occlusion: Ready for Prime Time?
por: Pothineni, Naga Venkata K., et al.
Publicado: (2021)

Left atrial appendage closure in atrial fibrillation patients with prior major bleeding or ineligible for oral anticoagulation
por: Wintgens, L. I. S., et al.
Publicado: (2019)

Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment—a systematic review and meta-analysis
por: Labori, Frida, et al.
Publicado: (2021)

Left atrial appendage occlusion procedures
por: Bartuś, Krzysztof
Publicado: (2017)

Left atrial appendage occlusion is underutilized
por: Huijboom, Marina F.M., et al.
Publicado: (2022)

Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation
por: Liu, Chaofan, et al.
Publicado: (2023)

Cardioembolic Stroke in Atrial Fibrillation-Rationale for Preventive Closure of the Left Atrial Appendage
por: Leithäuser, Boris, et al.
Publicado: (2009)

Percutaneous Left Atrial Appendage Occlusion for the Prevention of Stroke in Patients with Atrial Fibrillation: Review and Critical Appraisal
por: Schellinger, Peter D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2noa2j2lkj15431na23p90jet6